Article and Video CATEGORIES
As I mentioned in my post about the transition into March, I recently participated in a Medscape program on "A Multidisciplinary Approach to Incorporating Genotyping in NSCLC". It requires people to register on Medscape, and it's a program with docs as the target audience, but I think it would be of potential interest to some of the GRACE members.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…